BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNβ AND USES THEREOF

摘要

Methods, assays and kits for the identification, assessment and/or treatment of a subject having multiple sclerosis (MS) are disclosed.